Log in to save to my catalogue

Anti-Emetic Activity of the Novel Nonpeptide Tachykinin NK1 Receptor Antagonist Ezlopitant (CJ-11,97...

Anti-Emetic Activity of the Novel Nonpeptide Tachykinin NK1 Receptor Antagonist Ezlopitant (CJ-11,97...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1069233819

Anti-Emetic Activity of the Novel Nonpeptide Tachykinin NK1 Receptor Antagonist Ezlopitant (CJ-11,974) against Acute and Delayed Cisplatin-Induced Emesis in the Ferret

About this item

Full title

Anti-Emetic Activity of the Novel Nonpeptide Tachykinin NK1 Receptor Antagonist Ezlopitant (CJ-11,974) against Acute and Delayed Cisplatin-Induced Emesis in the Ferret

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Pharmacology, 2002-11, Vol.66 (3), p.144-152

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

The anti-emetic effects of a novel tachykinin NK 1 receptor antagonist, ezlopitant ((2S,3S-cis)-2-diphenylmethyl)- N--1-azabicyclo- [2.2.2]octan-3-amine), were investigated in ferrets. Ezlopitant inhibited [ 3 H]substance P ([ 3 H]SP) binding to the human, guinea pig, ferret and gerbil NK 1 receptors (K i = 0.2, 0.9. 0.6 and 0.5 nmol/l, respectivel...

Alternative Titles

Full title

Anti-Emetic Activity of the Novel Nonpeptide Tachykinin NK1 Receptor Antagonist Ezlopitant (CJ-11,974) against Acute and Delayed Cisplatin-Induced Emesis in the Ferret

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1069233819

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1069233819

Other Identifiers

ISSN

0031-7012

E-ISSN

1423-0313

DOI

10.1159/000063796

How to access this item